Apr 22, 2026
Q1 wrap of biotech/biopharma company-level control transactions announced in 2026 — target, acquirer, deal value, structure, premium, and a one-line “why it matters.”
Apr 21, 2026
Stay up to date with our live tracker of biotech/biopharma IPOs in 2026 — therapeutic area, lead asset + phase at IPO, pricing date, proceeds and valuation, plus aftermarket performance. Updated Weekly.
Live tracker of biotech/biopharma M&A in 2026: target, acquirer, announced date, deal value, upfront, structure, premium, and rationale. Updated weekly.
Private financings — Company, date, round, investors, therapeutic area, and a one-line “what they do.”
Apr 13, 2026
Stay up to date with our live tracker of biotech/biopharma licensing + partnering deals in 2026 — upfronts, milestones, royalties, rights/territory, and a one-line “why it matters.” Updated weekly.
